Effect of Mulberry Leaf Extract on Glucose Response of a Test Meal

October 5, 2023 updated by: Société des Produits Nestlé (SPN)
The aim of this study is to test the effects of Mulberry leaf extract on glucose response of a standardized complete meal when taken just before or when mixed with the meal.

Study Overview

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Vaud
      • Lausanne, Vaud, Switzerland, 1000
        • Nestlé Clinical Research Unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male and female participants
  • Healthy status (based on anamnesis)
  • Age between 18 and 45 years
  • BMI between 20 and 29.9 kg/m2
  • Ability to understand and sign an informed consent form

Exclusion Criteria:

  • Pregnant or lactating women
  • Major medical/surgical event in the last 3 months potentially interfering with study procedures and assessments
  • Known food allergy and intolerance to test product
  • Medically known cutaneous hypersensitivity to adhesives and plasters
  • Alcohol intake higher than 2 servings per day. A serving is 0.4 dl of strong alcohols, 1 dl of red or white wine, or 3 dl of beer.

Smokers

Volunteer who cannot be expected to comply with the protocol

Subject having a hierarchical link with the research team members.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control
Water administrated just before a meal
Oral administration
Experimental: Mulberry leaf extract before
250 mg of Mulberry leaf extract was administered before a standard meal
Oral administration
Experimental: Mulberry leaf extract during
250 mg of Mulberry leaf extract was administered during a standard meal
Oral administration

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-prandial glucose
Time Frame: Hour 0 to hour 3 after standard meal consumption
Incremental area under the curve
Hour 0 to hour 3 after standard meal consumption

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
C max glucose
Time Frame: Hour 0 to hour 3 after standard meal consumption
Incremental C max
Hour 0 to hour 3 after standard meal consumption
T max glucose
Time Frame: Hour 0 to hour 3 after standard meal consumption
Incremental T max
Hour 0 to hour 3 after standard meal consumption

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 24, 2020

Primary Completion (Actual)

February 7, 2020

Study Completion (Actual)

February 7, 2020

Study Registration Dates

First Submitted

September 30, 2021

First Submitted That Met QC Criteria

October 27, 2021

First Posted (Actual)

November 8, 2021

Study Record Updates

Last Update Posted (Actual)

October 6, 2023

Last Update Submitted That Met QC Criteria

October 5, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 19.09 NRC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-prandial Glycemia

Clinical Trials on Water

Subscribe